Is an 8.9 A1C Bad? What It Means for Your Health

An A1C of 8.9% is well above every major guideline target for diabetes management and places you in a range where the risk of serious complications climbs steeply. Translated into everyday blood sugar terms, 8.9% corresponds to an estimated average glucose of roughly 209 mg/dL, meaning your blood sugar has been running high around the clock for months. This is the kind of result that typically prompts a conversation with your doctor about intensifying treatment, not because one number defines your future, but because the longer A1C stays in this range, the more damage accumulates in blood vessels, nerves, kidneys, and eyes.

What 8.9% Actually Represents

A1C measures how much glucose has attached to hemoglobin in your red blood cells over the lifespan of those cells, roughly the previous two to three months.¹ Unlike a finger-stick reading, which captures a single moment, A1C gives a rolling average. That average is useful because complications from diabetes are driven less by any individual spike and more by sustained exposure to high glucose over time.

Using the widely adopted formula from the international A1C-Derived Average Glucose (ADAG) study, an A1C of 8.9% works out to an estimated average glucose of about 209 mg/dL.² For context, a non-diabetic person’s average glucose typically sits somewhere around 100 mg/dL, and most diabetes guidelines set a general A1C target below 7%, which corresponds to roughly 154 mg/dL. At 8.9%, your blood sugar has been running about 55 mg/dL higher than even that already-elevated target, consistently, for weeks on end.

Symptoms You May Already Be Feeling

One of the frustrating things about chronically elevated blood sugar is that your body can adjust to it, masking the damage with surprisingly few obvious symptoms. But research has identified a threshold at which most people with type 2 diabetes start noticing classic hyperglycemic symptoms: that threshold sits right around 8.9%.³ The symptoms that showed up most reliably were frequent urination and persistent tiredness. For people with type 1 diabetes, the symptom threshold was a bit higher, around 10%.

If you have an A1C of 8.9% and feel fine, that does not mean nothing is happening. Many people with blood sugar in this range have already adapted to feeling slightly off. They chalk up fatigue to a busy schedule or frequent bathroom trips to drinking more water. The absence of dramatic symptoms can create a false sense of security, but the internal damage from sustained high glucose does not wait for you to feel it.

How 8.9% Affects Your Blood Vessels and Organs

The complications of poorly controlled diabetes fall into two broad camps: damage to small blood vessels (microvascular) and damage to large ones (macrovascular). An A1C of 8.9% puts you at meaningfully elevated risk for both.

On the microvascular side, a large UK study found that the risk of complications like diabetic eye disease, kidney disease, and nerve damage rises progressively as A1C climbs, without any sharp cutoff. The risk begins increasing at around 7% and accelerates at higher levels. People with an A1C of 9.6% or above faced roughly 70% higher risk of developing microvascular disease compared to those near normal levels.⁴ At 8.9%, you are already deep into the zone where risk is climbing noticeably, even if you have not yet crossed into the very highest bracket.

For people who also have kidney disease, the picture is even more concerning. Research on individuals with severe chronic kidney disease found that risks for major cardiovascular events, microvascular complications, and hospitalization due to low blood sugar all increased significantly once A1C exceeded about 7.2%.⁵ An A1C of 8.9% in someone with compromised kidneys is a particularly urgent situation.

Heart Disease and Mortality Risk

The link between A1C and cardiovascular disease is one of the best-studied areas in diabetes research, and the findings at the 8.9% level are sobering. A systematic review pooling data from multiple studies found that people with diabetes whose A1C exceeded 9% had about 69% higher risk of dying from any cause compared to those with lower levels.⁶ Cardiovascular mortality showed a similar pattern. At 8.9%, you are sitting just below that 9% line, but the risk does not jump suddenly at a round number; it has been climbing for a while.

A separate registry study of patients with coronary artery disease found a U-shaped relationship, meaning both very low and very high A1C levels were associated with increased mortality. The sharpest increase was at the high end: those with A1C of 7.8% or above had roughly double the mortality risk compared to the reference group.⁷ If you already have heart disease and your A1C is 8.9%, bringing it down is one of the most impactful things you can do.

Why Treatment Often Escalates at This Level

Guidelines from major diabetes organizations treat A1C values in this range as a signal that current therapy is not enough. Both the American Association of Clinical Endocrinologists and the American Diabetes Association recommend strongly considering insulin therapy for people with type 2 diabetes whose A1C exceeds 9% to 10%, especially when symptoms like frequent urination, excessive thirst, unintentional weight loss, or ketosis are present.⁸ At 8.9%, you are right at the edge of this threshold, and your doctor may bring up insulin or combination injectable therapies even if you have been managing with oral medications alone.

This does not mean insulin is inevitable. Some people at 8.9% can be brought down with medication adjustments, newer drug classes like GLP-1 receptor agonists, or significant lifestyle changes. But the clinical reality is that the higher the A1C, the harder it becomes to close the gap with diet and pills alone. At this level, the conversation typically shifts from “let’s try one more thing” to “we need to bring this down reliably and soon.”

What Lifestyle Changes Can Realistically Accomplish

Lifestyle modifications are part of every diabetes treatment plan, but it helps to have realistic expectations about how far they can move the needle, particularly when you are starting from 8.9%. A randomized trial of people with prediabetes or early diabetes found that a low-carbohydrate diet reduced A1C by about 0.23% more than a usual diet over six months, along with meaningful weight loss.⁹ A smaller study of obese patients with type 2 diabetes saw A1C drop from 7.3% to 6.8% with a low-carb approach, along with a substantial improvement in how well the body responded to insulin.¹⁰

Those are real and meaningful improvements, but notice the scale. Dietary changes alone typically shave off fractions of a percentage point to maybe half a point. If you are at 8.9% and need to get below 7%, diet and exercise alone are unlikely to close a gap of nearly two full percentage points. They remain valuable, both for the direct glucose-lowering effect and for improvements in weight, blood pressure, and cholesterol, but at 8.9% they are almost always a complement to medication, not a substitute for it.

The Legacy Effect and Why Timing Matters

One of the most important findings in diabetes research over the past two decades is the concept researchers call the “legacy effect” or “metabolic memory.” The UK study mentioned earlier found that early A1C control had lasting effects on microvascular outcomes years later.⁴ In plain terms, the damage done during a period of high A1C does not fully reverse even after blood sugar comes down. Months or years spent at 8.9% leave a kind of biological residue that continues to increase your risk of complications even after you achieve better control.

This is not meant to be discouraging. It means that bringing A1C down from 8.9% to, say, 7.5% still makes a real difference, but the sooner it happens, the less accumulated damage there is to contend with. Waiting another year to “see how things go” has real costs that show up later.

When A1C Targets Are Intentionally Relaxed

Not everyone is aiming for the same number. The American Diabetes Association’s 2025 Standards of Care spell out different A1C goals depending on a person’s age, overall health, and life expectancy. For healthy older adults with few other medical conditions, the target remains below 7% to 7.5%. For older adults with multiple chronic illnesses, cognitive impairment, or significant functional limitations, the target relaxes to below 8%. And for those in very poor health or receiving end-of-life care, A1C numbers take a back seat entirely; the focus shifts to avoiding dangerously low blood sugar and keeping the person comfortable.¹¹

So for a frail 85-year-old with dementia and heart failure, an A1C of 8.9% might prompt a different conversation than for a 50-year-old who is otherwise healthy. The risks of aggressive glucose-lowering, especially hypoglycemia, can outweigh the benefits in people with limited life expectancy. That said, even with relaxed targets, 8.9% is above what most guidelines consider acceptable for nearly any patient category.

When the Number Itself Might Be Misleading

A1C is not infallible. Several conditions can push the reading higher or lower than your actual average glucose warrants. Anything that affects the lifespan of red blood cells or the structure of hemoglobin can throw off the result. Iron-deficiency anemia, certain hemoglobin variants common in some ethnic populations, chronic kidney disease, recent blood transfusions, and even some medications can distort A1C readings.¹²

If your A1C reads 8.9% but your home glucose readings consistently tell a different story, it is worth discussing with your doctor. Alternative markers like fructosamine or glycated albumin can provide a cross-check. For most people, though, A1C is reliable enough that an 8.9% result should be taken seriously rather than dismissed as a lab artifact.

Pregnancy and an A1C of 8.9%

For women with preexisting diabetes who are pregnant or planning to become pregnant, an A1C of 8.9% carries specific and serious risks. A study of 933 pregnancies in women with type 1 diabetes found that the risk of serious adverse outcomes, including congenital malformations, increased when A1C exceeded 6.9%.¹³ A separate study in women with pregestational diabetes found that pregnancies resulting in infants with congenital malformations had significantly higher average A1C levels, around 9.3%, compared to about 8.0% in unaffected pregnancies.¹⁴

At 8.9%, the risk is already substantially elevated. Most guidelines recommend that women with diabetes get their A1C as close to normal as safely possible before conception, ideally below 6.5%. If you are at 8.9% and considering pregnancy, working with your healthcare team to bring that number down before conceiving is one of the most protective steps you can take for the baby.

The Emotional Weight of a High A1C

A reading of 8.9% can feel like a report card, and not a good one. Research on young people with type 1 diabetes has shown that those experiencing both depressive symptoms and diabetes-related distress had significantly higher A1C values, averaging around 9.6%, compared to roughly 8.1% in those without psychological burden.¹⁵ The relationship likely runs in both directions: feeling overwhelmed makes it harder to manage blood sugar, and seeing high numbers feeds the sense of failure and frustration.

If you are looking at an A1C of 8.9% and feeling demoralized, that reaction is common and understandable. But treating it purely as a willpower issue misses the picture. Depression, burnout, medication access, food environment, sleep quality, and social support all influence A1C. Addressing the emotional and logistical barriers to management is not a soft add-on; it is often the thing that makes the medical plan actually work.

The Financial Side of Running High

Beyond the health consequences, sustained poor glycemic control is expensive. A retrospective study of adults with type 2 diabetes found that those with A1C below 7% had substantially lower total medical costs over a year compared to those with A1C at 7% or above, a pattern that held regardless of whether the threshold was set at 7%, 8%, or 9%.¹⁶ The gap widens over time. A modeling study of type 1 diabetes costs found that uncontrolled patients faced roughly double the healthcare expenditure at one year, and the disparity ballooned dramatically by 10 and 25 years, driven largely by hospitalizations and complications.¹⁷

These are population-level averages and the specific dollar figures vary by country and healthcare system, but the direction is consistent everywhere researchers have looked. Investing in bringing A1C down, whether through medications, devices, or time spent on meal planning, tends to pay for itself many times over by preventing the expensive downstream complications like dialysis, amputations, and cardiac procedures that accumulate when blood sugar runs unchecked for years.

Cognitive Health at Sustained High Glucose

An emerging area of concern for people with chronically elevated A1C is the effect on the brain. A review of the evidence linking diabetes and cognitive function found that each small increment in A1C was associated with measurable cognitive decline, and that both prediabetes and diabetes were linked to worsening cognitive outcomes over time.¹⁸ The mechanisms likely involve both direct glucose toxicity to brain cells and damage to the small blood vessels that supply them, the same microvascular injury that affects the eyes and kidneys.

At 8.9%, you are not on the verge of sudden cognitive collapse, but the cumulative toll of years at this level may contribute to earlier or more pronounced age-related decline in memory and thinking ability. This is another area where the legacy effect matters: the damage to brain vasculature builds quietly and may not announce itself until years later, making early intervention all the more important.